OSA20: Respiratory Rehabilitation in Obstructive Sleep Apneas

Sponsor
Università degli Studi 'G. d'Annunzio' Chieti e Pescara (Other)
Overall Status
Completed
CT.gov ID
NCT04412941
Collaborator
S. Spirito Hospital, Pescara, Italy (Other)
40
1
2
8.3
4.8

Study Details

Study Description

Brief Summary

The Obstructive Sleep Apnea is characterized by obstruction of the upper airway during sleep (for at least 10 sec), with repeated breathing pauses, accompanied by oxygen desaturation in the blood and by sleep interruption with repeated arousals.

The investigators hypothesized that good sleep hygiene, the execution of respiratory rehabilitation exercises, with specific myofascial exercises on the muscles that are compromised in the Obstructive Sleep Apnea, can improve the patient's clinical outcome and quality of life.

The objective of this study is to evaluate the effect of respiratory rehabilitation with myo-functional exercises in mild obstructive sleep.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Myofunctional exercises
  • Behavioral: The rules of sleep hygiene
N/A

Detailed Description

Patients: Eligible patients aged between 40 and 80 years old, with BMI < 30 and with a recent diagnosis of mild Obstructive Sleep Apnea evaluated with home night cardio-respiratory monitoring.

The investigators will exclude patients with one or more of the following conditions:

subjects who regularly use hypnoinductive drugs, with craniofacial malformations, who have suffered recent facial trauma, suffering from hypothyroidism, suffering from neuromuscular diseases, with recent strokes, severe obstructive nasal disease, systemic infectious diseases and neoplastic diseases.

Home night cardio-respiratory monitoring: all patients will be evaluated according to international guidelines (AAMS American Academy Sleep Medicine) with an instrument equipped with sensors for detection oral/nasal flow, snoring, chest/abdomen movements, pulse oximetry and heart rate.

Questionnaire: The investigators will employ questionnaires validated in Italy: Snoring frequency (derived from the Berlin questionnaire); subjective daytime sleepiness (Epworth questionnaire); quality of sleep (Pittsburgh sleep quality questionnaire).

Patients will be randomized into two groups randomly with a 1: 1 ratio: group 1 (treated group) or group 2 (control group) for a total of 20 patients per group (according to the sample size calculation reported in the protocol).

The treatment group will be subjected to an integrated rehabilitation protocol, composed of Respiratory rehabilitation exercises with diaphragmatic breathing, thoracic mobilization exercises and manual pompage techniques, followed by manual trigger point therapy techniques, (that were identified by palpation following the guidelines provided by Travell and Simons trigger point manual), the accessory inspiratory muscles like pectoralis minor muscle, scapula elevator muscle, Sternocleidomastoid muscle. The integrated rehabilitation protocol will be 45 minutes, 3 weekly sessions for 4 weeks, for a total of 12 consecutive sessions. Also, at every patient will be taught oropharyngeal exercises to perform at home twice a day (the duration of 15 minutes each session) involving in particular exercises for soft palate, tongue, facial and genio-glosso muscle.

Both in the treated group and the control group will be given a booklet with the rules for proper sleep hygiene because sleep is influenced by our lifestyle and various environmental factors can affect the quality of night sleep.

Study Design

Study Type:
Interventional
Actual Enrollment :
40 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Participant)
Primary Purpose:
Treatment
Official Title:
Myofascial Technique Combined With Myofunctional Exercises In Mild Obstructive Sleep Apnea-Hypopneas Syndrome: A Randomized Controlled Study
Actual Study Start Date :
May 22, 2020
Actual Primary Completion Date :
Nov 30, 2020
Actual Study Completion Date :
Jan 31, 2021

Arms and Interventions

Arm Intervention/Treatment
Experimental: Treatment group

Myofunctional exercises + home oropharyngeal exercises + the rules of sleep hygiene

Behavioral: Myofunctional exercises
Myofunctional exercises: Respiratory rehabilitation exercises with diaphragmatic breathing, thoracic mobilization exercises and manual pompage techniques, followed by manual trigger point therapy techniques, that were identified by palpation following the guidelines provided by Travell and Simons trigger point manual, the accessory inspiratory muscles like pectoralis minor muscle, scapula elevator muscle, Sternocleidomastoid muscle. Home oropharyngeal exercises: at every patient will be taught oropharyngeal exercises to perform at home twice a day (the duration of 15 minutes each session) involving in particular exercises for soft palate, tongue, facial and genio-glosso muscle. The rules of sleep hygiene: a list of behaviours that physiologically promote a good night's sleep.
Other Names:
  • home oropharyngeal exercises
  • the rules of sleep hygiene
  • Behavioral: The rules of sleep hygiene
    The rules of sleep hygiene: a list of behaviours that physiologically promote a good night's sleep.

    Active Comparator: Control group

    the rules of sleep hygiene

    Behavioral: The rules of sleep hygiene
    The rules of sleep hygiene: a list of behaviours that physiologically promote a good night's sleep.

    Outcome Measures

    Primary Outcome Measures

    1. Change From Baseline in apnea/hypopnea index (AHI) [4 months]

      AHI is an index used to indicate the severity of sleep apnea. It is represented by the number of apnea and hypopnea events per hour of sleep.

    2. Sleep questionnaires, Berlin Questionnaire [4 months]

      it consists of 3 categories related to the risk of sleep apnea (1-severity of snoring, 2- excessive daytime sleepiness, 3-history of obesity or high blood pressure). Depending on the answers and therefore the reported symptoms, it allows a subdivision in high risk or low risk of having apneas;

    3. Sleep questionnaires, Epworth Sleepiness Scale [4 months]

      it is a scale intended to measure daytime sleepiness with a short questionnaire; the answers range from normal (0) to intense (3) in eight different situations; a total score greater than 10 is considered excessive daytime sleepiness

    4. Sleep questionnaires, Pittsburgh Sleep Quality Index [4 months]

      It is a self-administered questionnaire that assesses sleep quality over a 1-month time interval. Evaluate seven sleep items on a scale of 0 to 3, 0 indicating no difficulty and 3 indicating severe difficulty. The results are expressed in an overall score (between 0 and 21). Values above 5 are consistent with poor sleep quality.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    40 Years to 80 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Diagnosis of mild Obstructive Sleep Apnea (5≤AHI≤14)

    • age between 40 and 80 years

    • BMI <30.

    Exclusion Criteria:
    • regular use of Hypno-inducing drugs,

    • severe nasal obstructive disease,

    • primary pulmonary pathology,

    • craniofacial malformations,

    • recent facial traumas,

    • hypothyroidism,

    • neuromuscular diseases,

    • recent stroke,

    • systemic infectious diseases,

    • neoplastic diseases.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Teresa Paolucci Chieti Abruzzo Italy 66100

    Sponsors and Collaborators

    • Università degli Studi 'G. d'Annunzio' Chieti e Pescara
    • S. Spirito Hospital, Pescara, Italy

    Investigators

    • Principal Investigator: Teresa Paolucci, MD, PhD, University G.d'annunzio - Chieti Pescara

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Paolucci Teresa, Principal Investigator; Research fellow, Università degli Studi 'G. d'Annunzio' Chieti e Pescara
    ClinicalTrials.gov Identifier:
    NCT04412941
    Other Study ID Numbers:
    • 1837-28.06.2019
    First Posted:
    Jun 2, 2020
    Last Update Posted:
    Oct 12, 2021
    Last Verified:
    Oct 1, 2021
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Paolucci Teresa, Principal Investigator; Research fellow, Università degli Studi 'G. d'Annunzio' Chieti e Pescara
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Oct 12, 2021